Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report.
Hoshino Y, Manaka K, Sato J, Asatsuma Y, Horikoshi H, Takeuchi M, Ito N, Fujita M, Yasunaga M, Matsuda K, Honda A, Maki H, Masamoto Y, Kurokawa M, Nangaku M, Makita N. Hoshino Y, et al. Among authors: horikoshi h. BMC Endocr Disord. 2023 Jun 5;23(1):128. doi: 10.1186/s12902-023-01384-5. BMC Endocr Disord. 2023. PMID: 37277771 Free PMC article.
Predictive factors for the effectiveness of novel androgen receptor axis-targeted agents in patients with metastatic prostate cancer.
Koshiro N, Nakajima K, Oyama M, Kaneko G, Takahashi S, Matsuyama H, Shiina H, Ichikawa T, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Mizokami A; PROSTAT-BSI Investigators. Koshiro N, et al. Among authors: horikoshi h. Int J Urol. 2022 Dec;29(12):1477-1487. doi: 10.1111/iju.15022. Epub 2022 Sep 7. Int J Urol. 2022. PMID: 36070138
Efficacy of Androgen Receptor-targeted Drugs After Prostate Cancer Recurrence With Bone Metastases: PROSTAT-BSI Sub-analysis.
Kamijima T, Yaegashi H, Mizokami A, Nakajima K, Matsuyama H, Ichikawa T, Nishimoto K, Takahashi S, Shiina H, Horikoshi H, Hashine K, Sugiyama Y, Miyao T, Kamiyama M, Harada K, Ito A, Enokida H. Kamijima T, et al. Among authors: horikoshi h. Anticancer Res. 2022 Jun;42(6):3099-3108. doi: 10.21873/anticanres.15798. Anticancer Res. 2022. PMID: 35641302
Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First Report.
Muraki Y, Maeda M, Inose R, Yoshimura K, Onizuka N, Takahashi M, Kawakami E, Shikamura Y, Son N, Iwashita M, Suzuki M, Yokoi M, Horikoshi H, Aoki Y, Kawana M, Kamei M, Hashiba H, Miyazaki C. Muraki Y, et al. Among authors: horikoshi h. Antibiotics (Basel). 2022 May 18;11(5):682. doi: 10.3390/antibiotics11050682. Antibiotics (Basel). 2022. PMID: 35625326 Free PMC article.
149 results